Back to Journals » Drug, Healthcare and Patient Safety » Volume 10

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]

Total article views   Abstract views HTML views PDF downloads Totals
1,509 Dovepress* 1,194 166+ 510 1,360
PubMed Central* 0 149 71 149
Totals 1,194 315 581 1,509
*Since 16 July 2018
+Since July 2016

View citations on PubMed Central and Google Scholar